See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2018_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,011,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,260,000 |
| 2 | PropertyPlantAndEquipmentNet | 178,000 |
| 3 | remainder_Assets | 775,000 |
| 4 | LiabilitiesCurrent | 7,929,000 |
| 5 | LiabilitiesNoncurrent | 42,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,303,772 |
| 9 | ResearchAndDevelopmentExpense | 12,215,252 |
| 10 | remainder_Expenses | -16,318,627 |
| 11 | remainder_Revenues | 11,187,482 |
| 12 | remainder_NetIncome | -1,180,675 |
| 13 | remainder_ComprehensiveNetIncome | 690,725 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 73,224,000 |
| 1 | Liabilities | 7,971,000 |
| 2 | Expenses | 11,200,397 |
| 3 | Revenues | 11,187,482 |
| 4 | StockholdersEquity | 65,253,000 |
| 5 | NetIncome | -1,193,590 |
| 6 | ComprehensiveNetIncome | -848,228 |
| 7 | BaseVar | 52,727,140 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.48 |
| 9 | EconomicCapitalRatio | 4.02 |